Show Notes
Prodromal autonomic dysfunction has emerged as an important area of research in understanding Lewy body diseases, including Parkinson's disease, and dementia with Lewy bodies. Dr. Michelle Matarazzo sits down with three experts in the field, Dr. Abhimanyu Mahajan, Dr. Alison Yarnall, and Dr. David Goldstein to discuss the current evidence behind various disturbances and how they may precede classic motor and cognitive symptoms, such as cardiovascular, gastrointestinal, urinary, and thermoregulatory disturbances. Together they discuss how these early non-motor manifestations may be considered integral features of the disease process. Read the related Scientific Issue Discussion on this topic.
More from MDS Podcast
Dr. Mitra Afshari discusses with Dr. Raul Martínez-Fernández recent advances in MRI-guided focused ultrasound for essential tremor and Parkinson’s disease, including improvements in safety and efficacy, its relationship with deep brain stimulation, and emerging neuromodulation approaches.
Dr. Eduardo de Pablo-Fernández discusses with Dr. Samuel Kim recent advances in Huntington’s disease, including genetic mechanisms, emerging biomarkers, and the potential of huntingtin-lowering therapies and gene therapy.
Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic approaches.
Ms. Nicole Duff discusses with Dr. Alison Yarnall the prevalence and impact of frailty in Parkinsonism, including how it is identified and measured and its implications for clinical trials and patient care.
Dr. Jerome Honnorat sits down with host Dr. Divyani Garg at the 2026 MDS international Congress to review the most recent advancements in autoimmune movement disorders.